Loading...
Market
What ranking will Abbott's Lingo CGM achieve among best-selling health devices in the US by end of 2024?
2
Resolution / Starting Odds
Top 10 • 25%
Top 20 • 25%
Top 50 • 25%
Outside Top 50 • 25%
Sales rankings from major retailers like Amazon, Walmart, or market research firms
Story
Abbott Launches $49 Lingo Over-the-Counter Continuous Glucose Monitor in U.S.
Sep 5, 2024, 01:16 PM
Abbott has launched its first over-the-counter continuous glucose monitor, Lingo, in the United States on Thursday. The device, priced at $49, is part of a new class of consumer-friendly biosensors designed to help users understand how their bodies respond to food, exercise, and stress. This marks a significant step in making health and wellness monitoring more accessible to the general public.
View original story
Similar markets
None • 25%
1 • 25%
2 • 25%
3 or more • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Top 5 • 25%
6 to 10 • 25%
11 to 20 • 25%
Below 20 • 25%
Below 3.0 stars • 25%
3.0 to 3.9 stars • 25%
4.0 to 4.4 stars • 25%
4.5 stars and above • 25%
Top 5 • 25%
6th to 10th • 25%
11th to 15th • 25%
Below 15th • 25%
0-10% • 25%
11-25% • 25%
26-50% • 25%
More than 50% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
1st to 3rd • 25%
4th to 6th • 25%
7th to 9th • 25%
10th or lower • 25%
Top 10 • 25%
Top 20 • 25%
Top 50 • 25%
Not in Top 50 • 25%
Wegovy • 25%
Zepbound • 25%
Ozempic • 25%
Other • 25%
Less than 50,000 • 25%
50,000 to 100,000 • 25%
100,000 to 150,000 • 25%
More than 150,000 • 25%